ID=wsj_1443.1 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Immunex N_175/N_175>) (<L N NNP NNP Corp. N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/S[dcl] VBD VBD said (S[dcl]\NP_8)/S[dcl]_9>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N PRP$ PRP$ its NP[nb]_166/N_166>) (<L N NNS NNS scientists N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBD VBD isolated (S[dcl]\NP_16)/NP_17>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_24/N_24>) (<L N NN NN molecule N>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT which (NP_34\NP_34)/(S[dcl]_35\NP_34:B)_35>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD may (S[dcl]\NP_44)/(S[b]_45\NP_44:B)_45>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB hold (S[b]\NP_52)/NP_53>) (<T NP 0 2> (<T NP 0 1> (<L N NN JJ potential N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN as (NP_64\NP_64)/NP_65>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_72/N_72>) (<L N NN NN treatment N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN for (NP_80\NP_80)/NP_81>) (<T NP 0 2> (<T NP 0 2> (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS disruptions N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_92\NP_92)/NP_93>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_100/N_100>) (<L N NN NN immune-system N>) ) ) ) (<L , , , , ,>) ) (<T NP\NP 0 1> (<T S[ng]\NP 0 2> (<T S[ng]\NP 0 2> (<L S[ng]\NP VBG VBG ranging S[ng]\NP_107>) (<T (S\NP)\(S\NP) 0 2> (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN from ((S_120\NP_115)_120\(S_120\NP_115)_120)/NP_121>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN organ-transplant N_130/N_130>) (<L N NN NN rejection N>) ) ) ) (<L , , , , ,>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP TO TO to ((S_146\NP_141)_146\(S_146\NP_141)_146)/NP_147>) (<T NP 0 1> (<T N 1 2> (<L N NNS NNS allergies N>) (<T N[conj] 1 2> (<L conj CC CC and conj>) (<L N NN NN asthma N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1443.2 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_212/N_212>) (<L N NN NN molecule N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ is (S[dcl]\NP_147)/NP_148>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_162/N_162>) (<T N 1 2> (<L N/N NN NN mouse N_157/N_157>) (<L N NN NN version N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_170\NP_170)/NP_171>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_178/N_178>) (<L N NN NN protein N>) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/NP VBN VBN called (S[pss]\NP_185)/NP_186>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_200/N_200>) (<T N 1 2> (<L N/N NN NN interleukin-4 N_195/N_195>) (<L N NN NN receptor N>) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1443.3 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NN NN IL-4 N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ is (S[dcl]\NP_67)/NP_68>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_75/N_75>) (<L N NN NN hormone N>) ) (<T NP\NP 0 2> (<L (NP\NP)/(S[dcl]\NP) WDT WDT which (NP_85\NP_85)/(S[dcl]_86\NP_85:B)_86>) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ directs (S[dcl]\NP_93)/NP_94>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_105/N_105>) (<T N 1 2> (<L N NN NN growth N>) (<T N[conj] 1 2> (<L conj CC CC and conj>) (<L N NN NN function N>) ) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_113\NP_113)/NP_114>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ white N_130/N_130>) (<T N 1 2> (<L N/N NN NN blood N_123/N_123>) (<L N NNS NNS cells N>) ) ) ) (<T NP\NP 0 1> (<T S[pss]\NP 0 2> (<L (S[pss]\NP)/PP VBN VBN involved (S[pss]\NP_138)/PP_139>) (<T PP 0 2> (<L PP/NP IN IN in PP/NP_144>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_168/N_168>) (<L N NN NN body N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_160/N_160)\NP_161>) ) (<T N 1 2> (<L N/N JJ JJ immune N_153/N_153>) (<L N NN NN response N>) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1443.4 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_173/N_173>) (<T N 1 2> (<L N/N NN NN IL-4 N_168/N_168>) (<L N NN NN receptor N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN on (NP_181\NP_181)/NP_182>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_189/N_189>) (<L N NN NN surface N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_197\NP_197)/NP_198>) (<T NP 1 2> (<L NP/NP JJ JJ such NP_208/NP_208>) (<T NP 0 1> (<L N NNS NNS cells N>) ) ) ) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ receives (S[dcl]\NP_101)/NP_102>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_159/N_159>) (<L N NN NN hormone N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_151/N_151)\NP_152>) ) (<T N 0 2> (<L N NN NN message N>) (<T N\N 0 1> (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_113)/(S[b]_114\NP_113:B)_114>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB rally (S[b]\NP_121)/NP_122>) (<T NP 1 2> (<T NP[nb]/N 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_139/N_139>) (<L N NN NN body N>) ) (<L (NP[nb]/N)\NP POS POS 's (NP[nb]_131/N_131)\NP_132>) ) (<L N NN NN defense N>) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1443.5 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<L S/S CC CC But S_323/S_323>) (<T S[dcl] 1 2> (<T S/S 0 2> (<L (S/S)/NP IN IN in (S_255/S_255)/NP_256>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ certain N_265/N_265>) (<L N NNS NNS conditions N>) ) ) (<T NP\NP 1 2> (<L (NP\NP)/(NP\NP) JJ JJ such (NP_316\NP_310)_316/(NP_316\NP_310)_316>) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN as (NP_274\NP_274)/NP_275>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ autoimmune N_284/N_284>) (<L N NNS NNS diseases N>) ) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 2> (<T NP 0 1> (<L N NNS NNS allergies N>) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN transplant N_297/N_297>) (<L N NN NN rejection N>) ) ) ) ) ) ) ) ) ) ) (<T S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNS NNS doctors N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD would (S[dcl]\NP_104)/(S[b]_105\NP_104:B)_105>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[to]\NP) VB VB like (S[b]\NP_114)/(S[to]_115\NP_114:B)_115>) (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_124)/(S[b]_125\NP_124:B)_125>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB damp (S[b]\NP_132)/NP_133>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_147/N_147>) (<T N 1 2> (<L N/N JJ JJ immune N_142/N_142>) (<L N NN NN response N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/S[dcl] IN IN so ((S_160\NP_155)_160\(S_160\NP_155)_160)/S[dcl]_161>) (<T S[dcl] 1 2> (<T NP 1 2> (<L NP/NP JJ JJ such NP_242/NP_242>) (<T NP 0 1> (<L N NNS NNS cells N>) ) ) (<T S[dcl]\NP 0 2> (<T (S[dcl]\NP)/(S[b]\NP) 0 2> (<L (S[dcl]\NP)/(S[b]\NP) VBP VBP do (S[dcl]\NP_170)/(S[b]_171\NP_170:B)_171>) (<L (S\NP)\(S\NP) RB RB n't (S_183\NP_178)_183\(S_183\NP_178)_183>) ) (<T S[b]\NP 0 2> (<T (S[b]\NP)/NP 0 2> (<L (S[b]\NP)/NP VB VB touch (S[b]\NP_190)/NP_191>) (<L (S\NP)\(S\NP) RP RP off (S_203\NP_198)_203\(S_203\NP_198)_203>) ) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ harmful N_219/N_219>) (<T N 1 2> (<L N/N JJ JJ inflammatory N_212/N_212>) (<L N NNS NNS reactions N>) ) ) ) (<T NP[conj] 1 2> (<L conj CC CC or conj>) (<T NP 0 1> (<T N 1 2> (<L N/N NN NN cell N_229/N_229>) (<L N NN NN destruction N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1443.6 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T S[dcl] 1 2> (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT A NP[nb]_324/N_324>) (<T N 1 2> (<L N/N JJ JJ soluble N_319/N_319>) (<L N NN NN form N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_332\NP_332)/NP_333>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_340/N_340>) (<L N NN NN receptor N>) ) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD might (S[dcl]\NP_221)/(S[b]_222\NP_221:B)_222>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<T (S[b]\NP)/NP 0 2> (<L (S[b]\NP)/NP VB VB turn (S[b]\NP_229)/NP_230>) (<L (S\NP)\(S\NP) RP RP off (S_242\NP_237)_242\(S_242\NP_237)_242>) ) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_256/N_256>) (<T N 1 2> (<L N/N JJ JJ specific N_251/N_251>) (<L N NN NN part N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_264\NP_264)/NP_265>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_279/N_279>) (<T N 1 2> (<L N/N JJ JJ immune N_274/N_274>) (<L N NN NN response N>) ) ) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN without ((S_292\NP_287)_292\(S_292\NP_287)_292)/NP_293>) (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ general N_309/N_309>) (<T N 1 2> (<L N/N JJ JJ immune N_302/N_302>) (<L N NN NN suppression N>) ) ) ) ) ) ) ) (<T S[dcl]\S[dcl] 1 2> (<L , , , , ,>) (<T S[dcl]\S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_210/N_210>) (<L N NN NN company N>) ) (<L (S[dcl]\S[dcl])\NP VBD VBD said (S[dcl]\S[dcl]_202)\NP_203>) ) ) ) (<L . . . . .>) ) 
ID=wsj_1443.7 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 1 2> (<L NP[nb]/N DT DT The NP[nb]_326/N_326>) (<T N 1 2> (<L N/N NN NN IL-4 N_321/N_321>) (<L N NN NN receptor N>) ) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/NP VBZ VBZ is (S[dcl]\NP_138)/NP_139>) (<T NP 0 2> (<T NP 0 1> (<L N CD CD one N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_150\NP_150)/NP_151>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N CD CD five N_167/N_167>) (<T N 1 2> (<L N/N JJ JJ such N_160/N_160>) (<L N NNS NNS receptors N>) ) ) ) (<T NP\NP 0 1> (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_177)/(S[b]_178\NP_177:B)_178>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/(S[pss]\NP) VB VB be (S[b]\NP_187)/(S[pss]_188\NP_187:B)_188>) (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<T S[pss]\NP 0 2> (<L S[pss]\NP VBN VBN developed S[pss]\NP_193>) (<T S[pss]\NP[conj] 1 2> (<L conj CC CC and conj>) (<L S[pss]\NP VBN VBN tested S[pss]\NP_198>) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN by ((S_213\NP_208)_213\(S_213\NP_208)_213)/NP_214>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Receptech N_223/N_223>) (<L N NNP NNP Corp. N>) ) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_231/N_231>) (<L N NN NN spinoff N>) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_239\NP_239)/NP_240>) (<T NP 0 1> (<L N NNP NNP Immunex N>) ) ) ) ) ) ) ) (<L , , , , ,>) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN through ((S_260\NP_255)_260\(S_260\NP_255)_260)/NP_261>) (<T NP 1 2> (<L NP[nb]/N DT DT a NP[nb]_307/N_307>) (<T N 1 2> (<L N/N VBN VBN proposed N_302/N_302>) (<T N 1 2> (<T N/N 0 2> (<L (N/N)/N[num] $ $ $ (N_285/N_285)/N[num]_286>) (<T N[num] 1 2> (<L N/N CD CD 30 N_295/N_295>) (<L N[num] CD CD million N[num]>) ) ) (<T N 1 2> (<L N/N JJ JJ initial N_277/N_277>) (<T N 1 2> (<L N/N JJ JJ public N_270/N_270>) (<L N NN NN offering N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1443.8 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP Immunex N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD will (S[dcl]\NP_164)/(S[b]_165\NP_164:B)_165>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<L (S[b]\NP)/PP VB VB contract (S[b]\NP_172)/PP_173>) (<T PP 0 2> (<L PP/NP IN IN with PP/NP_178>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_185/N_185>) (<L N NN NN spinoff N>) ) ) ) (<T (S\NP)\(S\NP) 0 1> (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_194)/(S[b]_195\NP_194:B)_195>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB provide (S[b]\NP_202)/NP_203>) (<T NP 0 2> (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_210/N_210>) (<L N NN NN research N>) ) (<T NP[conj] 1 2> (<L , , , , ,>) (<T NP 0 2> (<T NP 0 1> (<L N NN NN development N>) ) (<T NP[conj] 1 2> (<L conj CC CC and conj>) (<T NP 0 2> (<T NP 0 1> (<T N 1 2> (<L N/N JJ JJ initial N_222/N_222>) (<L N NN NN testing N>) ) ) (<T NP\NP 0 2> (<L (NP\NP)/NP IN IN of (NP_231\NP_231)/NP_232>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_246/N_246>) (<T N 1 2> (<L N/N JJ JJ new N_241/N_241>) (<L N NNS NNS agents N>) ) ) ) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
ID=wsj_1443.9 PARSER=GOLD NUMPARSE=1
(<T S[dcl] 0 2> (<T S[dcl] 1 2> (<T NP 0 1> (<L N NNP NNP Immunex N>) ) (<T S[dcl]\NP 0 2> (<L (S[dcl]\NP)/(S[b]\NP) MD MD will (S[dcl]\NP_89)/(S[b]_90\NP_89:B)_90>) (<T S[b]\NP 0 2> (<L (S[b]\NP)/NP VB VB have (S[b]\NP_97)/NP_98>) (<T NP 1 2> (<L NP[nb]/N DT DT the NP[nb]_174/N_174>) (<T N 0 2> (<L N NN NN option N>) (<T N\N 0 1> (<T S[to]\NP 0 2> (<L (S[to]\NP)/(S[b]\NP) TO TO to (S[to]\NP_109)/(S[b]_110\NP_109:B)_110>) (<T S[b]\NP 0 2> (<T S[b]\NP 0 2> (<T (S[b]\NP)/NP 0 2> (<L (S[b]\NP)/NP VB VB buy (S[b]\NP_117)/NP_118>) (<L (S\NP)\(S\NP) RP RP back (S_130\NP_125)_130\(S_130\NP_125)_130>) ) (<T NP 0 1> (<T N 1 2> (<L N/N NNP NNP Receptech N_139/N_139>) (<L N NNS NNS shares N>) ) ) ) (<T (S\NP)\(S\NP) 0 2> (<L ((S\NP)\(S\NP))/NP IN IN after ((S_153\NP_148)_153\(S_153\NP_148)_153)/NP_154>) (<T NP 0 1> (<T N 1 2> (<L N/N CD CD five N_163/N_163>) (<L N NNS NNS years N>) ) ) ) ) ) ) ) ) ) ) ) (<L . . . . .>) ) 
